Aaron N Hata

31PUBLICATIONS
355CO-AUTHORS
Molecular targetsProteins and peptidesPredictive and prognostic markersAnalytical spectrometryLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 05, 2026
M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.

|Jul 27, 2026
Systematic Targeting of Protein Complexes with Molecular COUPLrs.

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Apr 11, 2026
Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancer.

Brittany N Heil, Garima Baral, Claire M Pfeffer

|Apr 10, 2026
ApoFLARE: a luminescent reporter for direct quantification of APOBEC3A editing activity.

Maria Vittoria Di Marco, Braeden L Butler, Christopher T Eggers

|Feb 06, 2026
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung Cancer.

Takashi Sakai, Zofia Piotrowska, Charlotte I Wang

Pageof 6

Frequent Collaborators

5 joint publications

Jessica J Lin

3 joint publications

Kristopher Sarosiek

3 joint publications

Jacob E Berchuck

3 joint publications

Satoshi Yoda